Pinz Capital Management’s Imunon IMNN Stock Holding History

Pinz Capital Management’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-96	Closed	-$24K	–	255
2021 Q2	$24K	Buy	+96	New	+$22.7K	0.01%	314

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Pinz Capital Management's IMNN Position: Q3 2021 in Review

Pinz Capital Management sold out of Imunon (IMNN) in Q3 2021, closing a stake of 96 shares — an estimated $24K sold.

Pinz Capital Management first reported a position in IMNN in Q2 2021 and held it in 1 quarter. The position peaked at $24K in Q2 2021. 37 funds tracked by Wall St. Rank hold IMNN as of Q3 2021.

Pinz Capital Management reported no remaining Imunon position as of Q3 2021 after selling out during the quarter.
Pinz Capital Management sold 96 Imunon shares in Q3 2021, an estimated $24K.
Pinz Capital Management first reported a position in Imunon in Q2 2021 and held it in 1 quarter.
Pinz Capital Management's Imunon position peaked at $24K in Q2 2021.
37 funds tracked by Wall St. Rank held Imunon as of Q3 2021.

Based on Pinz Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.